NYSE:VOR

Vor Biopharma News Headlines

$27.25
-1.31 (-4.59 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$25.62
Now: $27.25▼
$29.61
50-Day Range
$28.56
MA: $37.22▼
$48.00
52-Week Range
$25.32
Now: $27.25▼
$63.62
Volume164,596 shs
Average Volume279,876 shs
Market Capitalization$1.01 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Vor Biopharma (NYSE VOR) News Headlines Today

SourceHeadline
Vor Biopharma (NYSE:VOR) Research Coverage Started at B. RileyVor Biopharma (NYSE:VOR) Research Coverage Started at B. Riley
marketbeat.com - March 30 at 8:26 AM
Vor Biopharma (NYSE:VOR) Shares Down 8.7% Vor Biopharma (NYSE:VOR) Shares Down 8.7%
americanbankingnews.com - April 15 at 1:39 PM
Vor Biopharma (NYSE:VOR) Trading 9.9% Higher Vor Biopharma (NYSE:VOR) Trading 9.9% Higher
americanbankingnews.com - April 14 at 2:34 PM
Vor Biopharma (NYSE:VOR) Shares Gap Down to $32.13Vor Biopharma (NYSE:VOR) Shares Gap Down to $32.13
americanbankingnews.com - April 13 at 1:42 PM
Vor Biopharma (NYSE:VOR) Shares Down 4.5% Vor Biopharma (NYSE:VOR) Shares Down 4.5%
americanbankingnews.com - April 7 at 12:32 PM
Vor Biopharma (NYSE:VOR) Shares Gap Down to $43.10Vor Biopharma (NYSE:VOR) Shares Gap Down to $43.10
americanbankingnews.com - April 5 at 11:40 AM
Vor Biopharma (NYSE:VOR) Trading Down 8%Vor Biopharma (NYSE:VOR) Trading Down 8%
americanbankingnews.com - April 1 at 12:36 PM
Vor Biopharma (NYSE:VOR) Trading 7% Higher Vor Biopharma (NYSE:VOR) Trading 7% Higher
americanbankingnews.com - March 31 at 12:00 PM
Vor Biopharma IncVor Biopharma Inc
reuters.com - March 30 at 10:32 PM
Vor Biopharma (NYSE:VOR) Sees Strong Trading VolumeVor Biopharma (NYSE:VOR) Sees Strong Trading Volume
americanbankingnews.com - March 30 at 11:45 AM
B. Riley Begins Coverage on Vor Biopharma (NYSE:VOR)B. Riley Begins Coverage on Vor Biopharma (NYSE:VOR)
americanbankingnews.com - March 30 at 9:44 AM
Vor Biopharma Reports FY20 Net Loss Of $43.3M Compared To $10.8M YoYVor Biopharma Reports FY20 Net Loss Of $43.3M Compared To $10.8M YoY
benzinga.com - March 25 at 8:48 PM
Vor Reports Fiscal Year 2020 Financial ResultsVor Reports Fiscal Year 2020 Financial Results
finance.yahoo.com - March 25 at 8:48 PM
Vor Biopharma Inc Registered Shs OverweightVor Biopharma Inc Registered Shs Overweight
markets.businessinsider.com - March 5 at 8:32 AM
Vor Biopharma Inc Registered Shs SellVor Biopharma Inc Registered Shs Sell
markets.businessinsider.com - March 4 at 10:03 AM
Vor Biopharma Inc Registered Shs BuyVor Biopharma Inc Registered Shs Buy
markets.businessinsider.com - March 4 at 10:03 AM
Vor Biopharma Announces Participation at Cowen 41st Annual Health Care ConferenceVor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference
finance.yahoo.com - March 1 at 8:09 PM
Biopharma Companies Flood Nasdaq’s IPO Pipeline in FebruaryBiopharma Companies Flood Nasdaq’s IPO Pipeline in February
nasdaq.com - February 26 at 6:04 PM
PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public OfferingPureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering
businesswire.com - February 10 at 8:37 AM
Vor Biopharma Inc Registered Shs Stock , VORVor Biopharma Inc Registered Shs Stock , VOR
markets.businessinsider.com - February 9 at 7:41 PM
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional SharesVor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
finance.yahoo.com - February 9 at 7:41 PM
This page was last updated on 4/21/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.